A novel toll-like receptor 4 (TLR4) antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis Running Title: Dual effect of anti-TLR4 antibody in murine colitis (original) (raw)

Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis

davide di fusco

European Journal of Clinical Pharmacology, 2020

View PDFchevron_right

The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease

Piotr Smolewski

Immunology, 2008

View PDFchevron_right

Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease: Toll-like receptor expression in inflammatory bowel disease

András Arató

Clinical and Experimental Immunology, 2007

View PDFchevron_right

Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis

Hilda Yanti

American Journal of Physiology-Gastrointestinal and Liver Physiology, 2004

View PDFchevron_right

Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP

Catalina Abad

Journal of Leukocyte Biology, 2005

View PDFchevron_right

Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis

A. Kraneveld

Mucosal Immunology, 2014

View PDFchevron_right

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases

G. Bromfield

Genes and Immunity, 2007

View PDFchevron_right

Increased expression of Toll‐like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease

Adám Vannay

Clinical & …, 2008

View PDFchevron_right

Activation of toll-like receptor 3 protects against DSS-induced acute colitis

Andrew Neish

Inflammatory Bowel Diseases, 2007

View PDFchevron_right

Carvalho, F.A. et al. Interleukin-1beta (IL-1beta) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 61, 373-384

Omry Koren

Gut

View PDFchevron_right

Interleukin11 Reduces TLR4Induced Colitis in TLR2Deficient Mice and Restores Intestinal STAT3 Signaling

Sanjoy Ghosh

Gastroenterology, 2010

View PDFchevron_right

Differential expression of key regulators of Toll-like Receptors in Ulcerative Colitis and Crohn's disease: A role for Tollip and PPARγ?

Trevor Darby

Clinical & Experimental Immunology, 2015

View PDFchevron_right

TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice

Jason Law

Journal of Clinical Investigation, 2010

View PDFchevron_right

T2074 The Expression of Toll-Like Receptor 4 in Colon Mucosa is as up-Regulated in Irritable Bowel Syndrome as it is in Inflammatory Bowel Disease

Greger Lindberg

Gastroenterology, 2010

View PDFchevron_right

Association between Toll-like receptor 4 and inflammatory bowel disease

klaas jansen

Inflammatory Bowel Diseases, 2005

View PDFchevron_right

Toll-Like Receptor 4 Contributes to Colitis Development but Not to Host Defense during Citrobacter rodentium Infection in Mice

Wanyin Deng

Infection and Immunity, 2006

View PDFchevron_right

Proinflammatory properties of IL-4 in the intestinal microenvironment

Stephen Collins

AJP: Gastrointestinal and Liver Physiology, 2005

View PDFchevron_right

IL-4 Receptor-Alpha Signalling of Intestinal Epithelial Cells, Smooth Muscle Cells, and Macrophages Plays a Redundant Role in Oxazolone Colitis

Patricia Odhiambo

Mediators of Inflammation, 2020

View PDFchevron_right

Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis

Caixia Ma

Cellular Microbiology, 2007

View PDFchevron_right

Toll-Like Receptor 4-Mediated Regulation of Spontaneous Helicobacter-Dependent Colitis in IL-10–Deficient Mice

Cathryn Nagler, Guénolée Prioult

Gastroenterology, 2009

View PDFchevron_right

Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome

Greger Lindberg

BioMed Research International, 2017

View PDFchevron_right

Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease

András Falus

2011

View PDFchevron_right

Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis

Uday Ghoshal

Journal of Neurogastroenterology and Motility, 2018

View PDFchevron_right

New concepts in the pathophysiology of inflammatory bowel disease

Giorgos Bamias, S. De La Rue

Annals of internal medicine, 2005

View PDFchevron_right

Regulation of mucosal immune responses — the missing link in IBD?

Kenneth Beagley

Inflammatory Bowel Disease, 1994

View PDFchevron_right

Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?

Fergus Shanahan

Clinical and Experimental Immunology, 2015

View PDFchevron_right

The Role of Innate Immunity Receptors in the Pathogenesis of Inflammatory Bowel Disease

Heitor S P de Souza

Mediators of inflammation, 2015

View PDFchevron_right

TLR Signaling-induced CD103-expressing Cells Protect Against Intestinal Inflammation

Julia-Stefanie Frick

Inflammatory Bowel Diseases, 2015

View PDFchevron_right

Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases

Warren Strober

Gastroenterology, 2011

View PDFchevron_right